CARBOGEN AMCIS - GREENFIELD INJECTABLES FACILITY

CARBOGEN AMCIS, pharmaceutical company dedicated to clinical development including API and drug product manufacturing,  is building a new 9,500 square meters facility dedicated to injectables. These new premises will enable CARBOGEN AMCIS to enlarge their services portfolio notably with complex formulation using various chemical and biological agents.

Pharmaplan designed an evolutive facility and conducted a containment risk assessment aiming to define the right strategy to handle high potent products. We developed a flexible design for process, to deal with clinical and commercial batches: development, formulation, and filling of freeze-dried and liquid products. The building will also include research & development and quality control laboratories, as well as administrative functions.

PROJECT RIOM2 – Greenfield
injectables facility
LOCATION Riom, France
CUSTOMER CARBOGEN AMCIS
DURATION 2017 – 2023
TIC 45 m. EUR
Carbogen AMICS, France, view 3
Carbogen AMICS, France, view 2
Previous slide
Next slide

Share Project